Management of Cefuroxime-Induced Allergic Rash
Assessing Reaction Severity and Documentation
- The American Academy of Allergy, Asthma, and Immunology recommends documenting the specific reaction characteristics, including timing, distribution, and associated symptoms, for future antibiotic selection 1
- The reaction severity should be determined, whether it is a non-severe delayed-type reaction or a severe cutaneous adverse reaction, to guide management decisions 2
- Red flags requiring immediate escalation include blistering or skin exfoliation, mucosal membrane involvement, which are indicative of severe reactions 1, 3
Future Antibiotic Selection
- The American Academy of Allergy, Asthma, and Immunology advises avoiding cephalosporins with identical R2 side chains to cefuroxime, such as cefotaxime, cefotetan, and cefaclor, due to potential cross-reactivity 1, 3
- Safe alternatives with dissimilar side chains, such as ceftriaxone, can be considered for non-severe delayed reactions 2
- Penicillins with dissimilar side chains can be used if the cefuroxime reaction was a non-severe delayed-type reaction, as cross-reactivity is R1 side chain-dependent 2, 3
- Carbapenems remain safe regardless of cefuroxime allergy type or severity 2